Conto economico

DEXCOM INC

DXCM
Annual
Riepilogo performance Clicca su una riga della tabella per aggiungerla al grafico
in milioni di USD
Voce Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY Dec 31, 2018 2018 FY Dec 31, 2017 2017 FY Dec 31, 2016 2016 FY Dec 31, 2015 2015 FY Dec 31, 2014 2014 FY Dec 31, 2013 2013 FY Dec 31, 2012 2012 FY Dec 31, 2011 2011 FY
Ricavi
4,662.00 4,033.00 3,622.30 2,909.80 2,448.50 1,926.70 1,476.00 1,031.60 718.50 573.30 402.00 259.20 160.00 99.90 76.27
Costo del venduto
1,860.10 1,594.80 1,333.40 1,026.70 768.00 646.60 544.50 367.70 - 194.90 123.60 82.90 59.90 53.30 40.42
Utile lordo
2,801.90 2,438.20 2,288.90 1,883.10 1,680.50 1,280.10 931.50 663.90 492.10 378.40 278.40 176.30 100.10 46.60 35.84
Spese operative
1,890.10 1,838.20 1,691.20 1,491.90 1,414.70 980.60 789.20 850.20 534.60 442.30 335.50 197.80 129.00 102.30 80.69
Ricerca e sviluppo
599.10 552.40 505.80 484.20 517.10 359.90 273.50 199.70 185.40 156.10 137.50 69.40 44.80 39.50 30.75
Spese commerciali, generali e amministrative
1,291.00 1,285.80 1,185.40 1,000.20 810.50 620.70 515.70 432.80 349.20 286.20 198.00 128.40 84.20 62.80 49.94
Altre spese operative
- - - - - - - - - - - - - - -
Reddito operativo
911.80 600.00 597.70 391.20 265.80 299.50 142.30 -186.30 -42.50 -63.90 -57.10 -21.50 -28.90 -55.70 -44.84
Proventi/oneri non operativi
-176.60 -109.00 -112.70 0.40 91.90 74.50 38.10 -59.80 6.10 1.00 0.40 0.80 0.90 0.10 -
Proventi da interessi
112.70 134.20 135.00 - - - - - 3.30 0.40 - - - - 0.11
Oneri finanziari
14.30 14.90 20.30 101.90 100.30 84.70 60.30 22.70 12.80 0.70 0.40 0.80 0.90 0.20 0.01
Altri proventi/oneri non operativi
176.60 109.00 112.70 18.00 -1.70 16.10 26.40 - 3.40 -0.70 - - - - 0.00
Risultato prima delle imposte
1,088.40 709.00 710.40 390.80 173.90 225.00 104.20 -126.50 -48.60 -64.90 -57.50 -22.30 -29.80 -55.80 -
Imposte sul reddito
252.10 132.80 168.90 49.60 19.20 -268.60 3.10 0.60 1.60 0.70 0.10 0.10 0.00 -55.80 -
Utile di pertinenza di terzi
- - - - - - - - - - - - - - -
Utile netto
836.30 576.20 541.50 341.20 154.70 493.60 101.10 -127.10 -50.20 -65.60 -57.60 -22.40 -29.80 0.00 0.00
Informazioni supplementari Dati per azione, voci derivate e altre – non facenti parte del conto economico
in milioni di USD, salvo diversa indicazione
Voce Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY Dec 31, 2018 2018 FY Dec 31, 2017 2017 FY Dec 31, 2016 2016 FY Dec 31, 2015 2015 FY Dec 31, 2014 2014 FY Dec 31, 2013 2013 FY Dec 31, 2012 2012 FY Dec 31, 2011 2011 FY
Ammortamenti e svalutazioni
- - - - - - - - - - - - - - -
EBITDA
1,163.60 817.70 783.70 547.10 367.80 366.60 191.00 -157.20 -26.40 -48.90 -46.30 -13.10 -21.90 -49.10 -41.08
Utile per azione (base)
2.14 1.46 1.40 0.88 1.60 5.23 1.11 - - - - - - - -
Utile per azione diluito
2.09 1.42 1.30 0.82 1.55 5.06 1.10 - - - - - - - -
Media ponderata azioni
390.20 393.60 386.00 389.40 96.70 94.40 91.10 - - - - - - - -
Media ponderata diluita azioni
405.50 412.70 425.50 427.50 100.10 97.50 92.30 - - - - - - - -
Conto economico complessivo
959.30 584.90 536.40 329.10 152.00 494.50 101.90 -123.00 -51.80 -66.30 -57.80 -22.40 -29.80 - 0.00